tiprankstipranks
Trending News
More News >
Medi Lifestyle Limited (SG:Z4D)
SGX:Z4D
Singapore Market

Medi Lifestyle Limited (Z4D) AI Stock Analysis

Compare
0 Followers

Top Page

SG:Z4D

Medi Lifestyle Limited

(SGX:Z4D)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
S$0.01
▲(10.00% Upside)
The score is held down primarily by weak financial performance—persistent losses, negative equity, and ongoing negative operating/free cash flow. Technicals provide some support via price strength above key moving averages, but momentum is mixed with an extremely high RSI. Valuation remains challenging due to negative earnings and no dividend yield data.
Positive Factors
Debt Reduction
A meaningful reduction in debt by 2024 improves solvency and reduces near-term financing pressure for a company with a weak equity base. Lower debt can extend runway, reduce interest costs and make future financing less dilutive or costly, aiding operational continuity.
Revenue Rebound
A very large reported revenue increase signals renewed demand or successful commercial execution versus prior years. If sustained, that top-line recovery can support scale economies, improve gross margins over time, and provide a path toward narrowing structural losses.
Market Liquidity
High average trading volume indicates relatively strong liquidity for the stock, which supports reliable price discovery and easier access to public capital. For a cash-burning operator, tradability aids the firm’s ability to raise equity or execute strategic transactions when needed.
Negative Factors
Negative Shareholder Equity
A multi-year negative equity position weakens the balance sheet's ability to absorb further losses, restricts borrowing capacity and may trigger creditor covenants or refinancing difficulties. This structural capital deficit raises long-term financial fragility risk.
Consistent Cash Burn
Repeated negative operating and free cash flows indicate the business cannot self-finance operations or invest without external funding. Persistent cash burn forces reliance on capital markets or creditors, increasing dilution risk and limiting strategic optionality over months.
Unprofitable Core Operations
A negative gross profit and large operating losses imply core unit economics are currently unviable. Structural margin problems like these suggest the business model or cost base needs material change to reach break-even, complicating durable profitability prospects.

Medi Lifestyle Limited (Z4D) vs. iShares MSCI Singapore ETF (EWS)

Medi Lifestyle Limited Business Overview & Revenue Model

Company DescriptionMedi Lifestyle Limited, an investment holding company, provides placement services in Malaysia, Singapore, and China. It operates through Healthcare, Outsourced Services, and Commodity Trading segments. The company offers postpartum recovery services under the NADORA brand; and alternative medicines and physical therapy services, such as chiropractic and physiotherapy, and traditional Chinese medicines under the Back to Life brand name. It also engages in agricultural commodities trading, including coffee beans and derivatives of palm oil; and marketing and sale of healthcare related products. In addition, the company provides recruitment agency, rendering confinement and postnatal care, consultancy, digital marketing, business process outsourcing, and human resource services. Further, it operates a postpartum care center, and chiropractic and physiotherapy centers. The company was formerly known as IEV Holdings Limited and changed its name to Medi Lifestyle Limited in November 2020. Medi Lifestyle Limited was founded in 1986 and is headquartered in Singapore.
How the Company Makes Money

Medi Lifestyle Limited Financial Statement Overview

Summary
Financial health appears high-risk: profitability is deeply negative with gross profit turning negative in 2024, shareholder equity is persistently negative (2021–2024), and operating/free cash flow are negative every year, indicating ongoing cash burn. Debt reduction in 2024 is a positive, but not enough to offset weak margins and cash generation.
Income Statement
12
Very Negative
Revenue has been volatile (down in 2022–2023, then a sharp rebound in 2024), but profitability remains very weak. Gross profit turned negative in 2024 and operating results are deeply loss-making across all years, with net margins consistently and materially negative—signaling a business still far from break-even despite the recent top-line recovery.
Balance Sheet
18
Very Negative
The balance sheet is strained, highlighted by persistently negative shareholder equity from 2021–2024, which increases financial risk and limits flexibility. Debt has come down meaningfully by 2024 versus 2021–2023, but leverage remains a concern given the equity deficit and ongoing losses.
Cash Flow
10
Very Negative
Cash generation is a major weakness: operating cash flow and free cash flow are negative in every year shown, including a large outflow in 2024. While free cash flow moved around year to year, the overall pattern suggests continued cash burn and reliance on external funding or balance sheet actions to sustain operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue5.39M1.84M1.94M2.40M1.40M204.46K
Gross Profit-108.00K-211.71K154.33K92.91K491.58K13.00K
EBITDA-4.01M-4.69M-6.18M-3.49M-9.15M-1.28M
Net Income-4.36M-5.34M-7.19M-4.30M-23.72M-907.35K
Balance Sheet
Total Assets2.46M1.86M811.50K2.18M4.03M6.88M
Cash, Cash Equivalents and Short-Term Investments296.00K1.07M106.11K510.06K1.22M162.74K
Total Debt1.25M1.57M3.84M3.53M4.96M2.50M
Total Liabilities4.71M3.45M10.03M10.89M9.96M4.38M
Stockholders Equity-2.24M-1.59M-9.22M-8.71M-5.93M2.50M
Cash Flow
Free Cash Flow-3.86M-6.54M-6.83M-2.31M-4.31M-3.56M
Operating Cash Flow-3.86M-6.54M-6.81M-2.12M-4.11M-3.45M
Investing Cash Flow0.000.00-24.83K-191.16K-197.61K534.28K
Financing Cash Flow4.58M7.54M6.38M1.44M5.02M2.89M

Medi Lifestyle Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
S$23.86M11.693.57%3.62%2.58%63.16%
64
Neutral
S$43.65M16.038.43%5.71%
55
Neutral
S$97.92M9.362.82%-17.82%-75.83%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
S$5.29M-1.51
43
Neutral
S$13.57M-4.50-9.72%-31.80%32.12%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:Z4D
Medi Lifestyle Limited
0.01
<0.01
40.00%
SG:5AU
AP Oil International Limited
0.15
0.03
26.09%
SG:5NF
Mencast Holdings Ltd.
0.09
0.07
244.44%
SG:BLZ
Advanced Holdings Ltd.
0.13
0.01
11.67%
DE:5HY
Hengyang Petrochemical Logistics Ltd.
0.06
-0.01
-14.29%
SG:C9Q
Sinostar PEC Holdings Limited
0.10
-0.02
-15.00%

Medi Lifestyle Limited Corporate Events

Medi Lifestyle Holds Extraordinary General Meeting to Vote on Inter-Conditional Resolutions
Jan 21, 2026

Medi Lifestyle Limited convened an Extraordinary General Meeting (EGM) on 22 December 2025 at its Singapore office, chaired by Executive Chairman and CEO Herry Pudjianto and attended by board members and senior management, with one director participating electronically. The meeting confirmed the presence of a quorum, took the previously circulated notice and circular as read, appointed a scrutineer and polling agent, and informed shareholders that three inter-conditional ordinary resolutions would be decided by poll voting, with no questions submitted in advance and shareholders invited to raise queries on the proposed resolutions during the session.

The most recent analyst rating on (SG:Z4D) stock is a Hold with a S$0.01 price target. To see the full list of analyst forecasts on Medi Lifestyle Limited stock, see the SG:Z4D Stock Forecast page.

Medi Lifestyle Announces Debt Conversion Approval for SGX Listing
Dec 9, 2025

Medi Lifestyle Limited has announced the receipt of a listing and quotation notice from the SGX-ST for the proposed conversion of outstanding debt into new ordinary shares. This conversion, involving 213,965,134 shares at S$0.015 each, is subject to shareholder approval and compliance with SGX-ST listing requirements. The announcement marks a significant step in the company’s financial restructuring, potentially impacting its market positioning and stakeholder interests.

Medi Lifestyle Secures Additional Loan from Lingholm Holdings
Nov 13, 2025

Medi Lifestyle Limited has entered into a new loan agreement with Lingholm Holdings Pte. Ltd., securing a non-interest bearing loan of up to S$204,000. This agreement follows previous loans from Lingholm, totaling S$3.4 million. The loan will be used for corporate exercises and includes terms allowing Lingholm to influence board changes, reflecting a strategic financial maneuver to support the company’s operations and governance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026